These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30391203)

  • 21. Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors.
    Aghaei I; Rostampour M; Shabani M; Naderi N; Motamedi F; Babaei P; Khakpour-Taleghani B
    Epilepsy Res; 2015 Nov; 117():23-8. PubMed ID: 26370914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cannabinoid receptor 1 and the peroxisome proliferator-activated receptor α in mediating anti-nociceptive effects of synthetic cannabinoids and a cannabinoid-like compound.
    Alsalem M; Haddad M; Aldossary SA; Kalbouneh H; Altarifi A; Jaffal SM; Abbas MA; Aldaoud N; El-Salem K
    Inflammopharmacology; 2019 Dec; 27(6):1131-1142. PubMed ID: 30945071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.
    Koch M; Kreutz S; Böttger C; Benz A; Maronde E; Ghadban C; Korf HW; Dehghani F
    Neurotox Res; 2011 Feb; 19(2):330-40. PubMed ID: 20221904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.
    Skaper SD; Facci L; Giusti P
    Mol Neurobiol; 2013 Oct; 48(2):340-52. PubMed ID: 23813098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial.
    Ghazizadeh-Hashemi M; Ghajar A; Shalbafan MR; Ghazizadeh-Hashemi F; Afarideh M; Malekpour F; Ghaleiha A; Ardebili ME; Akhondzadeh S
    J Affect Disord; 2018 May; 232():127-133. PubMed ID: 29486338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Basal Pharmacology of Palmitoylethanolamide.
    Rankin L; Fowler CJ
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Nutraceutical N-Palmitoylethanolamide (PEA) Reveals Widespread Molecular Effects Unmasking New Therapeutic Targets in Murine Varicocele.
    Antonuccio P; Marini HR; Micali A; Romeo C; Granese R; Retto A; Martino A; Benvenga S; Cuzzocrea S; Impellizzeri D; Di Paola R; Fusco R; Cervellione RM; Minutoli L
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33668991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms.
    Cristiano C; Pirozzi C; Coretti L; Cavaliere G; Lama A; Russo R; Lembo F; Mollica MP; Meli R; Calignano A; Mattace Raso G
    Brain Behav Immun; 2018 Nov; 74():166-175. PubMed ID: 30193877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis.
    Vaia M; Petrosino S; De Filippis D; Negro L; Guarino A; Carnuccio R; Di Marzo V; Iuvone T
    Eur J Pharmacol; 2016 Nov; 791():669-674. PubMed ID: 27720681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice.
    Cristiano C; Avagliano C; Cuozzo M; Liguori FM; Calignano A; Russo R
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice.
    Yu HL; Deng XQ; Li YJ; Li YC; Quan ZS; Sun XY
    Pharmacol Rep; 2011; 63(3):834-9. PubMed ID: 21857095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harnessing the anti-inflammatory potential of palmitoylethanolamide.
    Alhouayek M; Muccioli GG
    Drug Discov Today; 2014 Oct; 19(10):1632-9. PubMed ID: 24952959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
    Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
    Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
    Couch DG; Cook H; Ortori C; Barrett D; Lund JN; O'Sullivan SE
    Inflamm Bowel Dis; 2019 May; 25(6):1006-1018. PubMed ID: 31054246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy.
    Wallace VC; Segerdahl AR; Lambert DM; Vandevoorde S; Blackbeard J; Pheby T; Hasnie F; Rice AS
    Br J Pharmacol; 2007 Aug; 151(7):1117-28. PubMed ID: 17558434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence.
    Avagliano C; Russo R; De Caro C; Cristiano C; La Rana G; Piegari G; Paciello O; Citraro R; Russo E; De Sarro G; Meli R; Mattace Raso G; Calignano A
    Pharmacol Res; 2016 Nov; 113(Pt A):276-289. PubMed ID: 27616549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia.
    Holubiec MI; Romero JI; Suárez J; Portavella M; Fernández-Espejo E; Blanco E; Galeano P; de Fonseca FR
    Psychopharmacology (Berl); 2018 Oct; 235(10):2929-2945. PubMed ID: 30058012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.
    De Petrocellis L; Bisogno T; Ligresti A; Bifulco M; Melck D; Di Marzo V
    Fundam Clin Pharmacol; 2002 Aug; 16(4):297-302. PubMed ID: 12570018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a role for palmitoylethanolamide in the treatment of depression?
    Coppola M; Mondola R
    Med Hypotheses; 2014 May; 82(5):507-11. PubMed ID: 24630855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
    Britti D; Crupi R; Impellizzeri D; Gugliandolo E; Fusco R; Schievano C; Morittu VM; Evangelista M; Di Paola R; Cuzzocrea S
    BMC Vet Res; 2017 Aug; 13(1):229. PubMed ID: 28768536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.